Dudley MW - Search Results

1

Adenosine A₁ Receptor and Ligand Molecular Modeling.

Dudley MW, Peet NP, Demeter DA, Weintraub HJR, Ijzerman AP, Nordvall G, van Galen PJM, Jacobson KA. Dudley MW, et al. Drug Dev Res. 1993 Mar;28(3):237-243. doi: 10.1002/ddr.430280309. Drug Dev Res. 1993. PMID: 38239889 Free PMC article.

2

Conformationally restrained, chiral (phenylisopropyl)amino-substituted pyrazolo[3,4-d]pyrimidines and purines with selectivity for adenosine A1 and A2 receptors.

Peet NP, Lentz NL, Sunder S, Dudley MW, Ogden AM. Peet NP, et al. Among authors: dudley mw. J Med Chem. 1992 Aug 21;35(17):3263-9. doi: 10.1021/jm00095a024. J Med Chem. 1992. PMID: 1507211

3

Xanthines with C8 chiral substituents as potent and selective adenosine A1 antagonists.

Peet NP, Lentz NL, Dudley MW, Ogden AM, McCarty DR, Racke MM. Peet NP, et al. Among authors: dudley mw. J Med Chem. 1993 Dec 10;36(25):4015-20. doi: 10.1021/jm00077a004. J Med Chem. 1993. PMID: 8258823

4

A novel synthesis of xanthines: support for a new binding mode for xanthines with respect to adenosine at adenosine receptors.

Peet NP, Lentz NL, Meng EC, Dudley MW, Ogden AM, Demeter DA, Weintraub HJ, Bey P. Peet NP, et al. Among authors: dudley mw. J Med Chem. 1990 Dec;33(12):3127-30. doi: 10.1021/jm00174a004. J Med Chem. 1990. PMID: 2258897 No abstract available.

5

The synthesis and biological activity of a highly selective adenosine A2a receptor agonist.

Borcherding DR, Lentz NL, Weintraub PM, Dudley MW, Secrest R, Kastner PR, Peet NP. Borcherding DR, et al. Among authors: dudley mw. Nucleosides Nucleotides. 1999 Oct;18(10):2175-91. doi: 10.1080/07328319908044874. Nucleosides Nucleotides. 1999. PMID: 10616724

6

Activation of adenosine A3 receptors on macrophages inhibits tumor necrosis factor-alpha.

McWhinney CD, Dudley MW, Bowlin TL, Peet NP, Schook L, Bradshaw M, De M, Borcherding DR, Edwards CK 3rd. McWhinney CD, et al. Among authors: dudley mw. Eur J Pharmacol. 1996 Aug 29;310(2-3):209-16. doi: 10.1016/0014-2999(96)00272-5. Eur J Pharmacol. 1996. PMID: 8884219

7

Apparent regional differences in 5-HT1A binding may reflect [3H]8-OH-DPAT labeling of serotonin uptake sites.

Sprouse JS, McCarty DR, Dudley MW. Sprouse JS, et al. Among authors: dudley mw. Brain Res. 1993 Jul 16;617(1):159-62. doi: 10.1016/0006-8993(93)90629-2. Brain Res. 1993. PMID: 8374738

8

MDL 27,531 selectively reverses strychnine-induced seizures in mice.

Kehne JH, Kane JM, Miller FP, Ketteler HJ, Braun DL, Senyah Y, Chaney SF, Abdallah A, Dudley MW, Ogden AM, et al. Kehne JH, et al. Among authors: dudley mw. Br J Pharmacol. 1992 Aug;106(4):910-6. doi: 10.1111/j.1476-5381.1992.tb14434.x. Br J Pharmacol. 1992. PMID: 1327393 Free PMC article.

9

Guanine nucleotides are competitive inhibitors of N-methyl-D-aspartate at its receptor site both in vitro and in vivo.

Baron BM, Dudley MW, McCarty DR, Miller FP, Reynolds IJ, Schmidt CJ. Baron BM, et al. Among authors: dudley mw. J Pharmacol Exp Ther. 1989 Jul;250(1):162-9. J Pharmacol Exp Ther. 1989. PMID: 2545857

10

5-Aryl-3-(alkylthio)-4H-1,2,4-triazoles as selective antagonists of strychnine-induced convulsions and potential antispastic agents.

Kane JM, Staeger MA, Dalton CR, Miller FP, Dudley MW, Ogden AM, Kehne JH, Ketteler HJ, McCloskey TC, Senyah Y, et al. Kane JM, et al. Among authors: dudley mw. J Med Chem. 1994 Jan 7;37(1):125-32. doi: 10.1021/jm00027a015. J Med Chem. 1994. PMID: 8289185

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

34 results

Search Page